Cargando…
Prophylactic antibiotic regimens in tumour surgery (PARITY): a pilot multicentre randomised controlled trial
OBJECTIVE: Clinical studies of patients with bone sarcomas have been challenged by insufficient numbers at individual centres to draw valid conclusions. Our objective was to assess the feasibility of conducting a definitive multi-centre randomised controlled trial (RCT) to determine whether a five-d...
Autor principal: | Investigators, The PARITY |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
British Editorial Society of Bone and Joint Surgery
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4602191/ https://www.ncbi.nlm.nih.gov/pubmed/26423584 http://dx.doi.org/10.1302/2046-3758.49.2000482 |
Ejemplares similares
-
Prophylactic antibiotic regimens in tumour surgery (PARITY): protocol for a multicentre randomised controlled study
por: Ghert, Michelle, et al.
Publicado: (2012) -
Prophylactic antibiotic regimens in tumor surgery (PARITY) survey
por: Hasan, Khaled, et al.
Publicado: (2012) -
Prophylactic Antibiotic Regimens In Tumor Surgery (PARITY): a multi-center randomized controlled study comparing alternative antibiotic regimens in patients undergoing tumor resections with endoprosthetic replacements—a statistical analysis plan
por: Schneider, Patricia, et al.
Publicado: (2021) -
Prophylactic antibiotics in the prevention of infection after operative vaginal delivery (ANODE): a multicentre randomised controlled trial
por: Knight, Marian, et al.
Publicado: (2019) -
Multicentre, randomised, double-blind, placebo-controlled phase II study of prophylactic olanzapine for patients with metastatic breast cancer receiving T-DXd treatment: protocol for the ERICA study (WJOG14320B)
por: Sakai, Hitomi, et al.
Publicado: (2023)